ID: ALA1159891

Max Phase: Preclinical

Molecular Formula: C13H21NO3

Molecular Weight: 239.31

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(C)NCC(O)COc1ccccc1CO

Standard InChI:  InChI=1S/C13H21NO3/c1-10(2)14-7-12(16)9-17-13-6-4-3-5-11(13)8-15/h3-6,10,12,14-16H,7-9H2,1-2H3

Standard InChI Key:  WGJVNJGGPWONPI-UHFFFAOYSA-N

Associated Targets(non-human)

Beta-2 adrenergic receptor 182 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 239.31Molecular Weight (Monoisotopic): 239.1521AlogP: 0.92#Rotatable Bonds: 7
Polar Surface Area: 61.72Molecular Species: BASEHBA: 4HBD: 3
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.99CX Basic pKa: 9.67CX LogP: 0.83CX LogD: -1.40
Aromatic Rings: 1Heavy Atoms: 17QED Weighted: 0.66Np Likeness Score: -0.29

References

1. IJzerman AP, Aué GH, Bultsma T, Linschoten MR, Timmerman H..  (1985)  Quantitative evaluation of the beta 2-adrenoceptor affinity of phenoxypropanolamines and phenylethanolamines.,  28  (9): [PMID:2993621] [10.1021/jm00147a037]

Source